What was the significance of May 23 in relation to HGPI's release of the 'Key Points for the Era of AI Diagnostic Support'?

May 23 was designated as Rare Disease Day when HGPI published the discussion paper on AI diagnostic support.

Which organization released the 'Key Points for the Era of AI Diagnostic Support' on May 23?

The Health and Global Policy Institute (HGPI) released the 'Key Points for the Era of AI Diagnostic Support' on May 23.

What is the full name of the institute that published the AI diagnostic support paper on May 23?

The full name is the Health and Global Policy Institute, which published the paper on May 23.

On what specific date did HGPI publish the 'Key Points for the Era of AI Diagnostic Support' discussion paper?

HGPI published the 'Key Points for the Era of AI Diagnostic Support' on May 23.

Why was the release date of the HGPI discussion paper symbolically important for rare disease advocacy?

The release date, May 23, was Rare Disease Day, highlighting the relevance of AI diagnostic support for rare diseases.

Press Release: HGPI Publishes 'Key Points for the Era of AI Diagnostic Support'

Published May 26, 2026 3:00 AM ・ Updated Jun 14, 2026 3:57 PM ・ 2 min read ・ Source: PR TIMES

On May 23, designated as Rare Disease Day, the Health and Global Policy Institute (HGPI) released a discussion paper outlining key points for the social implementation of AI diagnostic support.

The Health and Global Policy Institute (HGPI) has published a discussion paper titled 'Key Points for the Era of AI Diagnostic Support' in conjunction with Rare Disease Day (May 23).

This paper organizes the issues that should be discussed across the sectors of citizens/patients, government, academia, and industry to accelerate the social implementation of AI diagnostic support, including Software as a Medical Device (SaMD).

Currently, the Japanese government plans to revise the 'Medical Device Basic Plan' to its third phase in April 2027, with an interim report released in March 2026. Following an expert meeting on April 17, 2026, and individual interviews, HGPI compiled this paper from an independent standpoint.

The points are organized into the following six areas: 1. Evidence construction 2. PMDA review systems and pharmaceutical affairs regulations 3. Post-market operations 4. Fostering understanding and trust among citizens and patients 5. The 'valley' of insurance reimbursement and economic incentives 6. Data utilization infrastructure and promoting development in the rare disease field

This paper is intended to serve as a material for policy discussions.

FACT BOX

Source: PR TIMES
Category: Survey

Press Release: HGPI Publishes 'Key Points for the Era of AI Diagnostic Support'

⚡ Key Points

FACT BOX

Editorial & Verification Standards

FAQ

Cite this article — HOW TO CITE

AI CRAWLER ACTIVITY